Contents of plasma М2-pyruvate kinase (M2-РК) in patients with inflammatory bowel diseases
Aim of investigation. Assessment of М2-pyruvate kinase level (M2-РК) at patients with ulcerative colitis (UC) and Crohn’s disease (CD) and its relation to course, clinical and endoscopical activity of disease.Material and methods. Overall 70 patients were investigated: 42 – with UC, 15 – with CD, 13...
Saved in:
Main Authors: | Ye. A. Konovich, I. L. Khalif |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2010-11-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1571 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunoassay for pyruvate kinase M1/2 as an Alzheimer’s biomarker in CSF
by: de Geus Matthijs B., et al.
Published: (2025-07-01) -
Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01) -
Sources of Bias in Common Diagnosis of Chronic Inflammatory Bowel Diseases
by: O. A. Svatkova, et al.
Published: (2020-12-01) -
Features of rectal treatment of inflammatory bowel diseases
by: D. V. Egorov, et al.
Published: (2023-07-01) -
Perinuclear antineutrophilic cytoplasmatic antibodies at patients with ulcerative colitis and Crohn’s disease
by: Ye. A. Konovich, et al.
Published: (2009-10-01)